The PI3K/AKT pathway, which promotes cell invasion and migration, is activated at the tumor rim, whereas the RAS-MARK pathway, which primarily enhances cell proliferation, is activated in the tumor core in the same tumor. The gene discussed is MARK1; the disease is neoplasm.